Organ Transplantation Market by Type, End User

Description

List of Tables

[181 Pages Report] The Organ Transplantation Market size was estimated at USD 16.45 billion in 2023 and expected to reach USD 18.07 billion in 2024, at a CAGR 10.30% to reach USD 32.69 billion by 2030.

The organ transplantation market encompasses all activities related to procuring, distributing, and transplanting human organs to patients requiring organ replacement therapy. It includes stakeholders such as organ donation agencies, transplant centers, healthcare facilities, pharmaceutical companies that provide anti-rejection medications, and biomedical companies that create artificial organs and support technologies. Application and end-use involve clinical procedures for replacing a faulty organ with a functioning organ from a donor, medical follow-up, and ongoing patient care for pre-and post-transplant scenarios. Several factors contribute to the growth of the organ transplantation market, including an increasing number of organ transplantation surgeries, the increasing prevalence of chronic diseases and accelerating cases of organ failure, and the development of legalized channels for organ donors and transplants. However, several limitations and challenges impact the adoption of organ transplantation, such as shortage of organ donors and high cost of treatment, risk of organ rejection and post-transplant complications, and social and ethical concerns in organ transplantation. On the other hand, technological advancement in organ transplantation methods, increasing awareness of organ donation, advancements in 3D bioprinting of organs and tissues, and personalized immunosuppression protocols to reduce the risk of rejection and complications present potential opportunities for the organ transplantation market in the coming years.

KEY MARKET STATISTICS
Base Year [2023]	USD 16.45 billion
Estimated Year [2024]	USD 18.07 billion
Forecast Year [2030]	USD 32.69 billion
CAGR (%)	10.30%

Type: Burgeoning kidney transplantation due to the increasing incidence of kidney diseases

Heart transplantation is a critical surgical procedure performed on patients with end-stage heart failure or extreme coronary artery disease when other surgical treatments fail. The demand for heart transplants usually outweighs the supply due to the limited availability of donor hearts. Kidney transplantation involves replacing a diseased kidney with a healthy one from a donor. This type of transplant is in high demand owing to the increasing incidence of kidney diseases, often resulting from hypertension and diabetes. Kidney transplants are usually more common than other organ transplants because kidneys can be donated by living donors, increasing the donor pool. Liver transplantation is the surgical alteration of a diseased liver with a complete or partial liver from a donor. This procedure is primarily indicated for patients with end-stage liver disease or acute liver failure, often due to conditions such as cirrhosis or hepatitis C. The market for liver transplantation includes pharmaceuticals for immunosuppression, along with biotechnology companies engaged in organ preservation solutions. Lung transplantation replaces diseased lungs with healthy lungs from a donor. It is generally reserved for individuals suffering from severe, life-threatening lung conditions such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, or pulmonary fibrosis. Pancreas transplantation is usually performed to treat type 1 diabetes, often in conjunction with kidney transplantation. This procedure can eliminate the need for insulin therapy for diabetic patients.

End User: Evolving organ transplantation in transplant centers owing to the specialization of staff and the technology

Hospitals and care providers play a pivotal role in the organ transplantation process. They are potential recipients' first point of contact and facilitate diagnosing treatment and post-transplant care. Their need-based preferences include high-quality, reliable organ preservation and transport systems to ensure organ viability, advanced surgical equipment, and operating room technology tailored for complex transplant operations. Transplant centers are specialized facilities that focus exclusively on organ transplants. They tend to be more advanced in terms of the specialization of staff and technology. Transplant centers' need-based preferences include the latest immunosuppressive drug protocols, treatments, and advanced tissue-typing technology to ensure better donor-recipient matches.

Regional Insights

The Americas represents a rapid growth in organ transplantation due to a robust healthcare infrastructure, established organ donation networks, and significant investments in research and development. Consumers in the US show high awareness regarding organ donation and transplantation, leading to substantial demand for related services. The organ transplantation market in South America is expanding, with countries such as Brazil and Argentina at the forefront. The markets are driven by governmental initiatives to increase organ donation rates and improve transplantation services. Europe exhibits a robust healthcare infrastructure and comprehensive organ transplant policies, with countries, including Spain, recognized for their efficient donor management systems. The incorporation of advanced technologies and the availability of specialized transplantation services contribute to the growth of this market. The Middle East showcases a growing organ transplant market driven by increasing healthcare spending and evolving regulatory frameworks. Cultural and religious factors significantly impact consumer behavior concerning organ donation and transplants. In Africa, organ transplantation activities are hindered by infrastructure challenges and disparities in healthcare. However, some regions are making strides in establishing transplantation programs but face obstacles with funding, public awareness, and regulatory hurdles. The APAC region is experiencing rapid development in the organ transplantation market, driven by the increasing prevalence of chronic diseases, rising healthcare expenditures, and government initiatives to promote organ donation. China is rapidly growing in organ transplantation due to substantial investments in healthcare infrastructure and a growing middle class. Japan has a well-established healthcare system, with specific challenges related to an aging population and cultural resistance to organ donation. India represents a complex organ transplant market with vast disparities in access to healthcare services. There's growing demand, particularly within urban centers, with private hospitals leading transplantation services.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Organ Transplantation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Organ Transplantation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Organ Transplantation Market, highlighting leading vendors and their innovative profiles. These include 21st Century Medicine, AbbVie Inc., Arthrex, Inc., Artivion, Inc., Astellas Pharma Inc., Bio-Rad Laboratories, Inc., BiolifeSolutions, Inc., CHIESI Farmaceutici S.p.A. by Amryt Pharma PLC, Dr. Franz Kohler Chemie GmbH, Exactech, Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Medtronic PLC, NHS Blood and Transplant, Novartis AG, Organ Recovery Systems, Organovo Holdings, Inc., OrganOx Limited, Pfizer Inc., Plexision, Preservation Solutions, Inc., Sanofi S.A., Stryker Corporation, Teva Pharmaceuticals Industries Ltd., Thermo Fisher Scientific Inc., TransMedics Group, Inc., Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp., and Xvivo Perfusion AB.

Market Segmentation & Coverage

This research report categorizes the Organ Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Heart Transplantation
- Kidney Transplantation
- Liver Transplantation
- Lung Transplantation
- Pancreas Transplantation

End User
- Hospitals & Care Providers
- Transplant Centers

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Organ Transplantation Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Organ Transplantation Market?

3. What are the technology trends and regulatory frameworks in the Organ Transplantation Market?

4. What is the market share of the leading vendors in the Organ Transplantation Market?

5. Which modes and strategic moves are suitable for entering the Organ Transplantation Market?

Product Code: MRR-437896AA3BAA

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing Number of Organ Transplantation Surgeries
  - 5.1.1.2. Increasing Prevalence of Chronic Diseases and Accelerating Cases of Organ Failure
  - 5.1.1.3. Development of Legalized Channel for Organ Donors and Transplants
- 5.1.2. Restraints
  - 5.1.2.1. Shortage of Organ Donors and High Cost of Treatment
- 5.1.3. Opportunities
  - 5.1.3.1. Technological Advancement in Organ Transplantation Methods
  - 5.1.3.2. Increasing Awareness of Organ Donation
- 5.1.4. Challenges
  - 5.1.4.1. Social and Ethical Concerns in Organ Transplantation
5.2. Market Segmentation Analysis
- 5.2.1. Type: Burgeoning kidney transplantation due to the increasing incidence of kidney diseases
- 5.2.2. End User: Evolving organ transplantation in transplant centers owing to the specialization of staff and the technology
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization

6. Organ Transplantation Market, by Type

6.1. Introduction
6.2. Heart Transplantation
6.3. Kidney Transplantation
6.4. Liver Transplantation
6.5. Lung Transplantation
6.6. Pancreas Transplantation

7. Organ Transplantation Market, by End User

7.1. Introduction
7.2. Hospitals & Care Providers
7.3. Transplant Centers

8. Americas Organ Transplantation Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Organ Transplantation Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Organ Transplantation Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
- 11.3.1. TransMedics Signs Definitive Agreement to Acquire Summit Aviation to Expand TransMedics Aviation Capabilities for Organ Transplantation
- 11.3.2. LiveOnNY and MediGO Collaborate to Launch Real-Time Organ Tracking Technology to Increase Transparency and Accountability Within the Organ Donation and Transplant Ecosystem
- 11.3.3. PAHO and Spain Sign Agreement to Strengthen Organ Donation and Transplant in the Americas

12. Competitive Portfolio

12.1. Key Company Profiles
12.2. Key Product Portfolio